Home524816 • BOM
add
Natco Pharma Ltd.
Previous close
₹1,022.05
Day range
₹995.80 - ₹1,029.75
Year range
₹560.15 - ₹1,107.85
Market cap
179.11B INR
Avg Volume
32.78K
P/E ratio
14.11
Dividend yield
0.95%
Primary exchange
NSE
In the news
Financials
Income Statement
Revenue
Net income
| (INR) | Dec 2023info | Y/Y change |
|---|---|---|
Revenue | 7.59B | 54.03% |
Operating expense | 3.72B | 19.12% |
Net income | 2.13B | 241.41% |
Net profit margin | 28.04 | 121.66% |
Earnings per share | 11.88 | 248.39% |
EBITDA | 2.63B | 167.05% |
Effective tax rate | 17.01% | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Dec 2023info | Y/Y change |
|---|---|---|
Cash and short-term investments | 12.16B | 21.00% |
Total assets | — | — |
Total liabilities | — | — |
Total equity | 52.94B | — |
Shares outstanding | 179.04M | — |
Price to book | 3.46 | — |
Return on assets | — | — |
Return on capital | 10.10% | — |
Cash Flow
Net change in cash
| (INR) | Dec 2023info | Y/Y change |
|---|---|---|
Net income | 2.13B | 241.41% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Natco Pharma is an Indian multinational pharmaceutical company based in Hyderabad. The company manufactures finished dosage formulations active pharmaceutical ingredients and crop health science products, and also provides contract manufacturing services. It is a major producer of branded oncology medicines and hepatitis C drugs. The company specialises in producing complex medicines at affordable prices. In 2019, Natco launched its crop health sciences division. Wikipedia
Founded
1981
Headquarters
Website
Employees
3,946
